Accelerating Antibody Drug Discovery Through Computational Modeling
1:15:12
Innovations from the therapeutics antibody space: obligate bispecific antibodies & T cell engagers
20:20
Machine learning in drug discovery at Bayer Pharmaceuticals: from models to molecules
23:35
DNASTAR - Antibody Prediction and Protein-Protein Docking Webinar
40:38
Archon's Jamie Lazarovits on Unlocking the Full Power of Antibodies With AI
1:32:31
Ákos Tarcsay (ChemAxon): Computational tools for drug discovery
1:08:53
Latest Advancements in Antibody Engineering – Bispecifics, Diagnostic Controls, and More
42:46
Where the Rubber Hits the Road - Applying Machine Learning on Drug Discovery Projects; Pat Walters
44:22